Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis

JM Gwinnutt, S Leggett, M Lunt, A Barton… - …, 2020 - academic.oup.com
Objectives Work is an important health outcome. This study aimed to identify predictors of
work loss, absenteeism and presenteeism over 1 year in RA patients commencing treatment …

Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis

J Gwinnutt, S Leggett, M Lunt… - Rheumatology …, 2020 - research.manchester.ac.uk
Objectives: Work is an important health outcome. This study aimed to identify predictors of
work loss, absenteeism and presenteeism over one year in rheumatoid arthritis (RA) …

[HTML][HTML] Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis

JM Gwinnutt, S Leggett, M Lunt, A Barton… - Rheumatology …, 2020 - ncbi.nlm.nih.gov
Objectives Work is an important health outcome. This study aimed to identify predictors of
work loss, absenteeism and presenteeism over 1 year in RA patients commencing treatment …

Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis.

JM Gwinnutt, S Leggett, M Lunt, A Barton… - …, 2020 - search.ebscohost.com
Objectives Work is an important health outcome. This study aimed to identify predictors of
work loss, absenteeism and presenteeism over 1 year in RA patients commencing treatment …

Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis

JM Gwinnutt, S Leggett, M Lunt… - Rheumatology …, 2020 - pubmed.ncbi.nlm.nih.gov
Objectives Work is an important health outcome. This study aimed to identify predictors of
work loss, absenteeism and presenteeism over 1 year in RA patients commencing treatment …

Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis

JM Gwinnutt, S Leggett, M Lunt, A Barton, KL Hyrich… - Rheumatology, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Objectives</jats: title>< jats: p>
Work is an important health outcome. This study aimed to identify predictors of work loss …

Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis.

JM Gwinnutt, S Leggett, M Lunt, A Barton… - Rheumatology …, 2020 - europepmc.org
Objectives Work is an important health outcome. This study aimed to identify predictors of
work loss, absenteeism and presenteeism over 1 year in RA patients commencing treatment …

[PDF][PDF] Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis

JM Gwinnutt, S Leggett, M Lunt, A Barton… - …, 2020 - academic.oup.com
Objectives Work is an important health outcome. This study aimed to identify predictors of
work loss, absenteeism and presenteeism over 1 year in RA patients commencing treatment …

Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis

JM Gwinnutt, S Leggett, M Lunt, A Barton… - …, 2020 - research.monash.edu
Work is an important health outcome. This study aimed to identify predictors of work loss,
absenteeism and presenteeism over 1 year in RA patients commencing treatment with MTX …

[PDF][PDF] Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis

JM Gwinnutt, S Leggett, M Lunt, A Barton… - …, 2020 - pdfs.semanticscholar.org
Objectives. Work is an important health outcome. This study aimed to identify predictors of
work loss, absenteeism and presenteeism over 1 year in RA patients commencing treatment …